Published in Am J Transplant on January 01, 2003
A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation. Clin Exp Immunol (2005) 0.94
Acute interstitial nephritis - a reappraisal and update. Clin Nephrol (2014) 0.89
Chemokines and their receptors in human renal allotransplantation. Transplantation (2011) 0.87
Compartmentalization of intracellular proinflammatory cytokines in bronchial intraepithelial T cells of stable lung transplant patients. Clin Exp Immunol (2006) 0.85
Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection. Am J Pathol (2007) 0.82
Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol (2012) 0.79
Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology (2007) 2.21
Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest (2007) 2.01
Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma. Eur Urol (2008) 1.56
Contribution of Toll-like receptor activation to lung damage after donor brain death. Transplantation (2010) 1.47
Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β. J Leukoc Biol (2012) 1.40
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology (2006) 1.37
Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem (2006) 1.35
Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol (2004) 1.25
Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med (2004) 1.17
A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J Immunol (2005) 1.12
T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor. Mol Immunol (2009) 1.05
Comment on "CXCL9 Causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation". J Immunol (2013) 1.05
Metal-on-metal hips: cobalt can induce an endotoxin-like response. Ann Rheum Dis (2012) 1.04
Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-β1-dependent mechanism. Free Radic Biol Med (2012) 1.02
Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation (2003) 1.01
Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J (2009) 0.97
Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids? Clin Cancer Res (2007) 0.96
Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate. J Cell Sci (2003) 0.95
Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2. Mol Immunol (2006) 0.95
The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant (2005) 0.94
Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration. Lab Invest (2004) 0.91
Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection. Transplantation (2013) 0.89
Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation. Proc Natl Acad Sci U S A (2012) 0.89
Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12. J Pathol (2014) 0.89
Renal transplantation: examination of the regulation of chemokine binding during acute rejection. Transplantation (2005) 0.88
Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation (2008) 0.88
Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation. J Cell Mol Med (2010) 0.85
Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation (2003) 0.84
Cancer stem cells and side population cells in breast cancer and metastasis. Cancers (Basel) (2011) 0.84
Leukocyte extravasation: an immunoregulatory role for alpha-L-fucosidase? J Immunol (2008) 0.84
An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Mol Immunol (2006) 0.83
Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells. Transplantation (2003) 0.83
Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Lab Invest (2002) 0.83
T cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection. Liver Transpl (2010) 0.82
Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology (2002) 0.82
Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens. J Clin Pathol (2013) 0.82
The role of FOXP3 in the development and metastatic spread of breast cancer. Cancer Metastasis Rev (2012) 0.82
Norepinephrine and arginine vasopressin increase hepatic but not renal inflammatory activation during hemodynamic resuscitation in a rodent model of brain-dead donors. Exp Clin Transplant (2009) 0.81
Renal allograft rejection: examination of delayed differentiation of Treg and Th17 effector T cells. Immunobiology (2012) 0.80
Cardiac allograft rejection: examination of the expression and function of the decoy chemokine receptor D6. Transplantation (2010) 0.80
Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology (2002) 0.80
Antibody-mediated allograft rejection: the emerging role of endothelial cell signalling and transcription factors. Transpl Immunol (2011) 0.79
Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology (2004) 0.79
Adhesion of lymphocytes to bladder cancer cells: the role of the alpha(E)beta(7) integrin. Cancer Immunol Immunother (2002) 0.79
In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids. J Gene Med (2007) 0.78
Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells. Mol Immunol (2008) 0.78
Stem cell therapy: a role for CXCR4 in homing bone marrow side population cells to areas of myocardial damage. Int J Cardiol (2010) 0.78
Transplantation and inflammation: implications for the modification of chemokine function. Immunology (2014) 0.78
B lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cells. Eur J Immunol (2011) 0.78
Brain stem auditory evoked response for confirmation of brain death in the rat. Transplantation (2008) 0.77
Evaluation of dendritic cell immunogenicity after activation and chemical fixation: a mixed lymphocyte reaction model. J Immunother (2002) 0.77
Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway. Hepatology (2008) 0.77
Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver Int (2008) 0.76
Nitric oxide during perfusion improves posttransplantation function of non- heart-beating donor lungs. Transplantation (2003) 0.76
The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology (2008) 0.76
A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology (2005) 0.76
Treatment of the brain-dead lung donor with aprotinin and nitric oxide. J Heart Lung Transplant (2010) 0.75
Post-transplant immunosuppression: regulation of the efflux of allospecific effector T cells from lymphoid tissues. PLoS One (2012) 0.75
The molecular mechanism of cell activation by cobalt ions. Comment on Ninomiya et al.: Metal ions activate vascular endothelial cells and increase lymphocyte chemotaxis and binding. J Orthop Res (2013) 0.75
Activation and modulation of cardiac poly-adenosine diphosphate ribose polymerase activity in a rat model of brain death. Transplantation (2008) 0.75
Oral tolerisation to pyruvate dehydrogenase complex as a potential therapy for primary biliary cirrhosis. Autoimmunity (2002) 0.75
Rapid site-directed mutagenesis of chemokines and their purification from a bacterial expression system. J Immunol Methods (2003) 0.75